378 related articles for article (PubMed ID: 27214604)
1. Discovery and characterization of antibody variants using mass spectrometry-based comparative analysis for biosimilar candidates of monoclonal antibody drugs.
Li W; Yang B; Zhou D; Xu J; Ke Z; Suen WC
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1025():57-67. PubMed ID: 27214604
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry.
Gahoual R; Biacchi M; Chicher J; Kuhn L; Hammann P; Beck A; Leize-Wagner E; François YN
MAbs; 2014; 6(6):1464-73. PubMed ID: 25484058
[TBL] [Abstract][Full Text] [Related]
3. Comparison of originator and biosimilar therapeutic monoclonal antibodies using comprehensive two-dimensional liquid chromatography coupled with time-of-flight mass spectrometry.
Sorensen M; Harmes DC; Stoll DR; Staples GO; Fekete S; Guillarme D; Beck A
MAbs; 2016 Oct; 8(7):1224-1234. PubMed ID: 27362833
[TBL] [Abstract][Full Text] [Related]
4. Characterization of alanine to valine sequence variants in the Fc region of nivolumab biosimilar produced in Chinese hamster ovary cells.
Li Y; Fu T; Liu T; Guo H; Guo Q; Xu J; Zhang D; Qian W; Dai J; Li B; Guo Y; Hou S; Wang H
MAbs; 2016 Jul; 8(5):951-60. PubMed ID: 27050807
[TBL] [Abstract][Full Text] [Related]
5. The criticality of high-resolution N-linked carbohydrate assays and detailed characterization of antibody effector function in the context of biosimilar development.
Brady LJ; Velayudhan J; Visone DB; Daugherty KC; Bartron JL; Coon M; Cornwall C; Hinckley PJ; Connell-Crowley L
MAbs; 2015; 7(3):562-70. PubMed ID: 25898160
[TBL] [Abstract][Full Text] [Related]
6. Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.
Zhu L; Guo Q; Guo H; Liu T; Zheng Y; Gu P; Chen X; Wang H; Hou S; Guo Y
MAbs; 2014; 6(6):1474-85. PubMed ID: 25484062
[TBL] [Abstract][Full Text] [Related]
7. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies.
Xie H; Chakraborty A; Ahn J; Yu YQ; Dakshinamoorthy DP; Gilar M; Chen W; Skilton SJ; Mazzeo JR
MAbs; 2010; 2(4):379-94. PubMed ID: 20458189
[TBL] [Abstract][Full Text] [Related]
8. A global comparability approach for biosimilar monoclonal antibodies using LC-tandem MS based proteomics.
Chen SL; Wu SL; Huang LJ; Huang JB; Chen SH
J Pharm Biomed Anal; 2013 Jun; 80():126-35. PubMed ID: 23563225
[TBL] [Abstract][Full Text] [Related]
9. Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies.
Beck A; Debaene F; Diemer H; Wagner-Rousset E; Colas O; Van Dorsselaer A; Cianférani S
J Mass Spectrom; 2015 Feb; 50(2):285-97. PubMed ID: 25800010
[TBL] [Abstract][Full Text] [Related]
10. Hydrophilic Interaction Chromatography Hyphenated with Mass Spectrometry: A Powerful Analytical Tool for the Comparison of Originator and Biosimilar Therapeutic Monoclonal Antibodies at the Middle-up Level of Analysis.
D'Atri V; Fekete S; Beck A; Lauber M; Guillarme D
Anal Chem; 2017 Feb; 89(3):2086-2092. PubMed ID: 28208257
[TBL] [Abstract][Full Text] [Related]
11. Tracking the Behavior of Monoclonal Antibody Product Quality Attributes Using a Multi-Attribute Method Workflow.
Jakes C; Millán-Martín S; Carillo S; Scheffler K; Zaborowska I; Bones J
J Am Soc Mass Spectrom; 2021 Aug; 32(8):1998-2012. PubMed ID: 33513021
[TBL] [Abstract][Full Text] [Related]
12. Characterization by liquid chromatography combined with mass spectrometry of monoclonal anti-IGF-1 receptor antibodies produced in CHO and NS0 cells.
Beck A; Bussat MC; Zorn N; Robillard V; Klinguer-Hamour C; Chenu S; Goetsch L; Corvaïa N; Van Dorsselaer A; Haeuw JF
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):203-18. PubMed ID: 15833284
[TBL] [Abstract][Full Text] [Related]
13. Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximab.
Dyck YFK; Rehm D; Winkler K; Sandig V; Jabs W; Parr MK
J Pharm Biomed Anal; 2023 Oct; 235():115596. PubMed ID: 37540995
[TBL] [Abstract][Full Text] [Related]
14. Detection and identification of a serine to arginine sequence variant in a therapeutic monoclonal antibody.
Ren D; Zhang J; Pritchett R; Liu H; Kyauk J; Luo J; Amanullah A
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Oct; 879(27):2877-84. PubMed ID: 21900054
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications.
Duivelshof BL; Jiskoot W; Beck A; Veuthey JL; Guillarme D; D'Atri V
Anal Chim Acta; 2019 Dec; 1089():1-18. PubMed ID: 31627805
[TBL] [Abstract][Full Text] [Related]
16. [Structural characterization and analysis of Omalizumab and its biosimilar CMAB007 by LC-MS].
Xu J; Zhang D; Wang H; Guo H
Sheng Wu Gong Cheng Xue Bao; 2016 Apr; 32(4):497-506. PubMed ID: 28853271
[TBL] [Abstract][Full Text] [Related]
17. Characterization of drug-product-related impurities and variants of a therapeutic monoclonal antibody by higher energy C-trap dissociation mass spectrometry.
Wang D; Wynne C; Gu F; Becker C; Zhao J; Mueller HM; Li H; Shameem M; Liu YH
Anal Chem; 2015 Jan; 87(2):914-21. PubMed ID: 25513708
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive approach for evaluating charge heterogeneity in biosimilars.
Xiao Z; Yin X; Han L; Sun B; Shen Z; Liu W; Yu F
Eur J Pharm Sci; 2018 Mar; 115():19-24. PubMed ID: 29325754
[TBL] [Abstract][Full Text] [Related]
19. Characterization of monoclonal antibody size variants containing extra light chains.
Lu C; Liu D; Liu H; Motchnik P
MAbs; 2013; 5(1):102-13. PubMed ID: 23255003
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods.
Li W; Yang B; Zhou D; Xu J; Li W; Suen WC
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
